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Abstract: In this article, we sought to assess the prevalence of hepatitis C (HCV) as well as somesocio­demographic characteristics of HCV­positive blood donors of the center of Alagoas. The medicalrecords of donors from a blood center in Alagoas were analyzed. The enzyme­linked immunosorbentassay (ELISA) was used for detection of antibodies against HCV, within the period from 2001 to 2004.Samples with positive serology by ELISA were analyzed through the confirmatory RIBA test. 45,832donations were collected at the blood center. Out of them, 0.62% had positive serology for hepatitis C.With regard to the variables, there was a prevalence of 86.7% for males, with ages ranging from 31 to40 years. Only 201 people returned to repeat ELISA. Out of these, 42.3% had repeated positiveserology by ELISA. For confirmation by RIBA, only 97 donors returned: 55.4% were positive, 15.7%negative, and 9.1% indeterminate. The studies show the need for more specific serological screeningtests.
Descriptors: Hepatitis C, Enzyme­linked immunosorbent assay, Blood donors.
Prevalência da hepatite C em doadores do hemocentro de Alagoas
Resumo: Neste artigo, buscou­se avaliar a prevalência de Hepatite C (HCV) bem como algumascaracterísticas sócio­demográficas dos doadores de sangue HCV positivo do Hemocentro de Alagoas.Foram analisados os prontuários dos doadores de um hemocentro em Alagoas. Foi utilizado o ensaiode imunoadsorção enzimática (ELISA) para a detecção de anticorpos contra o VHC, no período de2001 a 2004. Foram realizadas 45.832 doações no hemocentro. Destas, 0,62% apresentaramsorologia reativa para hepatite C. Em relação às variáveis, houve predominância de 86,7% para o sexomasculino, com idade entre 31 a 40 anos. Compareceram para repetição do ELISA apenas 201pessoas. Destas, 42,3% apresentaram sorologia repetidamente reagente pelo ELISA. Paraconfirmação pelo RIBA, apenas 97 doadores retornaram: 55,4% foram reagentes, 15,7% nãoreagentes e 9,1% indeterminados. Os estudos apontam para a necessidade de uma triagem sorológicacom testes mais específicos.
Descritores: Hepatite C, Ensaio de imunoadsorção enzimática, Doadores de sangue.
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Introduction
Viral hepatitis represents a major public health problem worldwide, featuring aninfectious process which affects, in varying degrees, the functioning of liver.1 Currently, thereare five known types of viral hepatitis, classified as A, B, C, D, and E; there are also threeother viruses that may be associated to hepatotropism as hepatitis G virus (GBV), transmittedtransfusion virus (TTV), and SEM­V.2
In the 1970s there was found evidence that the majority of cases of hepatitis due toblood transfusion was caused by a different type of virus; in the beginning, this virus wasdesignated non­A and non­B. It was verified that the virus particle could persist and maintainthe infection for a long time, and that its transmission occurred through the serum or plasma,afterwards this virus was named hepatitis C virus (HCV).3
HCV belongs to the family Flaviviridae. It is an enveloped RNA virus with single strandedgenome of 9.7 kb, positive polarity.4­5 The main forms of transmission of HCV occur throughcontact with blood and blood derivatives, via transfusion, shared use of contaminated needlesand syringes, and transplantation of organs.1,6
About 70% of individuals infected with HCV are asymptomatic, complicating earlydetection, because the biochemical changes (e.g. the increase in serum transaminases andbilirubin) caused by liver dysfunction are small in cases of hepatitis C.7­8
The number of chronic HCV patients in the world spans more than 180 million people.9In Brazil, it is not possible to obtain this estimate, due to lack of data, but it is estimated thatthe prevalence of HCV is about 3% in the general population.4
In 1900, the blood and blood derivatives sector in Brazil faced technical problemsbecause it did not have a specific health policy. Therefore, its activities were carried outempirically. After the emergence of cases of acquired immunodeficiency syndrome (AIDS),new policies began to be adopted.10 Then, in 1988, with the advent of Law 7,649, signed onJanuary 25, 1988, the registration of blood donors and completion of laboratory tests of bloodcollected for hepatitis B, Chagas disease, Syphilis, Malaria, and AIDS became mandatory, inorder to prevent the spread of these diseases.11
In 1993, Portaria 1,376 from the National Agency of Sanitary Surveillance (ANVISA)turned mandatory to include testing for HCV antibodies in the screening tests, in order to tryto reduce the transmission of the two forms of hepatitis through blood transfusion.12
The importance of detection of HCV in donors through serological tests is remarkable,aiming to guarantee the quality of blood to be donated and, thereby, contributing to reduce thespread of infection in the population, generally, when using the blood bags supplied by bloodcenters.
This paper aims to evaluate the epidemiological profile of hepatitis C in blood donorsfrom a blood center in Alagoas, Brazil, through a study on the positivity of hepatitis markers inblood donors, taking into account the demographic and socioeconomic variables.
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Methods
The medical records of 286 blood donors at the Maceio Blood Center, Alagoas, Brazil,within the period from January 2001 to December 2004, were analyzed; they showed reactiveor indeterminate serology for HCV by enzyme­linked immunosorbent assay (ELISA).Seropositive samples by ELISA were analyzed through confirmatory RIBA test. The socialcharacteristics of all donors with positive or indeterminate serology for HCV (gender, age,education level, skin color, and marital status) were also analyzed. Numerical variables wererepresented as means and standard deviation and the categories were represented with "n"and total percentages.
In the analysis of variables, those with the lowest p­value in the chi­square test wereconsidered representative. Means were compared through Student's t­test, and a p­valueequal to or less than 0.05 was considered significant. The software used was GraphPadPrism.
This study was carried out in accordance with the ethical standards for studies involvinghuman beings, and it was approved by the Research Ethics Committee of the School ofBiological and Health Sciences of Centro Universitario CESMAC, with a favorable opinionissued on July 13, 2009, under the Protocol 664/09.
Results and discussion
From 2001 to 2004 45,832 donations were collected at the Blood Center of Maceio, withan annual average of 11,460 donors (± 291). The annual average of donors with reactiveserology for HCV was 71.50 ± 10.76. One can notice a small drop in the number of reagentdonors for HCV in the last four years, with the exception of 2002. There was a statisticalsignificance (p < 0.0001) regarding the number of donors with reactive serology (Table 1).
Out of the 45,832 blood donors, 286 (0.62%) showed reactive serology for hepatitis Cusing ELISA test. Among these donors, 201 underwent repeat ELISA test, and 121 (60.20%)were positive again. Invited to return for confirmation, only 91 attended and the positiveserology for HCV was present in 67 (73.60%) of them (Table 2).
No significant difference was found with regard to skin color, marital status, education,and gender of blood donors with reactive serology for HCV. However, when it was used theRIBA test was evidenced greater prevalence of positive HCV in the group > 50 years (Table3).
A similar situation occurred when the social characteristics of these donors wereanalyzed, there is a variation of these characteristics at different stages of confirmatory tests,but one social characteristic showed an interesting profile, that is, most donors who returnedfor confirmatory testing had low education, demonstrating that this is not reflected in theirknowledge level, while donors with higher education had a lesser attendance to perform thetests, indicating a low knowledge level on the part of these people.
In Brazil, according to data from ANVISA13, 1.7% of the population donates blood andwithin this population the state of Alagoas represents 2% of the donations in the country.Blood centers are concerned with using increasingly more specific laboratory tests, aiming toincrease the safety of blood derivatives supplied to the population. The standardized
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procedure at the blood center of Alagoas is to dispose the bags with repeated serologicalpositive results by anti­HCV ELISA. Thus, reagent donors should have their positivityconfirmed through more specific tests. Therefore, aiming to keep the donor, confirmation isperformed with the immunoblot/RIBA test; but it is important to emphasize that the bloodcenter of Alagoas used immunoblot/RIBA as a confirmatory test for HCV only from January2001 to December 2004, corresponding to the study period of this research, because it hasbeen determined that providing the diagnosis of infection to the donor is not a responsibility ofthe blood center.
In Brazil, still there are few studies showing the prevalence of hepatitis C among blooddonors. Recently, ANVISA began to group the data and it shows that, in the Brazilian publicblood centers, the prevalence of HCV infection among blood donors was 0.5% in 2002.
Our results showed a HCV prevalence of 0,62% detected by ELISA test among donorsfrom the blood center of Alagoas. In the period from 2000 to 2002, ANVISA observed a 0.69%seroprevalence in the Northeast Region of the country and a 0.72% seroprevalence in thestate of Alagoas.14 In São Luis, Maranhão, Brazil, some studies show a drop in the positivityrates of anti­HCV. In the period from 1994 to 1998 there was an 1.41% prevalence, by 2002this number dropped to 0.54%, confirming the data found by ANVISA.15
After the confirmatory tests (repeated ELISA and RIBA), the seroprevalence droppedfrom 0.62% to 0.15%. Immunoenzymatic techniques can produce false­positive results due tothe presence of some residual proteins of the microorganism used as a vector for cloningrecombinant antigens which are present in the serological kits; it can also occur inautoimmune patients or in serum stored for long periods16. However, we cannot assert thatthis decreased seroprevalence after performing RIBA is a result of false positive generated byELISA test since only 31.82% returned to confirm the results obtained previously.
The comparison between the tests showed that RIBA is a much more specific test,evidencing that ELISA test generates false­positive results. These results demonstrate theneed for confirmation of screening tests.
There was a higher predominance of males (86.7%) among reagent blood donors. Thisresult confirms data presented by ANVISA14, where 79% of the donors’ population is male.
It was shown that female participation in donations is very low throughout the country.Regardless of gender when was used the RIBA test, the results obtained showed that donorswith reactive serology were aged from > 50 years (47.6%), single (57.34%), and they hadincomplete primary education (43.71%).
Contrary to our results, one study did not observe any association to different age groupsand genders.16 Another study observed a higher prevalence of males (83.6%), aged from 26to 45 years.17
A study carried out with 242,726 volunteer donors within the period 2004­2006 found thatthe largest group of donors consisted of males aged from 18 to 29 years, where 0.46% wereserologically reactive for anti­HCV antibodies.18
Conclusion
We observed that many donors with reactive serology on screening tests were notconfirmed through more specific tests, as they did not return for further analyses. Thus, theresults reinforce the need for performing a high quality serological analysis in blood centers, in
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order to provide an early diagnosis of hepatitis to this donor population and guarantee thequality of blood to be donated, thereby contributing to decrease the spread of infection in thepopulation. In addition, the disposal of blood bags represents a great loss for the bloodcenters throughout the Country due to the difficulty of maintaining stocks of hemocomponentssatisfactorily.
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Addendum
Table 1— Number of blood donors who had positive serology for hepatitis C at the Maceio Blood Center within the period from2001 to 2004.
Table 2 — Results of serological tests for hepatitis C carried out in blood donors at the Maceio Blood Center within the periodfrom 2001 to 2004.
p­value > 0.05 for a, b and c. Student's t­test.
Table 3 —Age group of blood donors at the Maceio Blood Center within the period from 2001 a 2004.
* p­value: < 0.0052, with statistical significance.
Year n(%) n(%)
2001 11,214 (24.5) 79 (27.5)
2002 12,323 (27) 96 (33.5)
2003 11,237 (24.5) 66 (23)
2004 11,058 (24) 45 (16)
TOTAL 45,832 286
Donors Positive serology for HCV
Anti­HCV 1st ELISA 2nd ELISA RIBA
n(%) n(%) n(%)
Positive 286 (0.62) 121 (60.20)a 67 (73.60)a
Inconclusive ­ 7 (3.50)b 3 (3.30)bNegative 45,546 (99.39) 73 (36.30)c 21 (23.10)c
TOTAL 45,832 201 91
SEROLOGICAL TEST
24­30 35 12.24 9 7.40 5 7.50
31­40 90 31.46 32 26.50 11 16.40 0.005241­50 83 29.00 36 29.80 19 28.50
> 50* 78 27.30 44 36.30 32 47.60
Total 286 100.00 121 100.00 67 100.00
Age group (years)N % N % N %
value
Social
characteristics 1st ELISA 2nd ELISA RIBA p­
Positive serology
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